Current work of UKL-HD

27 April, 2021
The third year of iPC project has started and in order to present the current work that each consortium partner is developing, we asked them to summarize the processes that are being done behind the project. This week we present the Heidelberg University (UKL-HD) where the team explains the current work that they are developing within iPC:

“Finding the most suitable treatment for each patient leads better prognosis and less side effects. We work on finding therapeutic targets and more efficient treatments. We use network-based approaches and machine learning algorithms applied to molecular big data.”